Latest Articles

Discovered in the 1970s, the mechanisms of RNA splicing have been well characterized through numerous studies in eukaryotic and prokaryotic systems. In this article, we describe the mechanisms of alternative splicing and further explore its role in molecular biology.

Biotech companies often have great difficulty accessing high quality patient samples to support their R&D. So, what can be done to provide industry, and particularly small biotech companies, with the high-quality, reliable samples they need?

This article covers the challenges associated with conventional vaccine approaches and elaborates on some of the recent innovations which can help design better vaccines.

Severe acute respiratory syndrome coronavirus-2, the causal agent of the ongoing coronavirus pandemic, has been evolving ever since the first outbreak in December 2019. Researchers believe that rapid vaccination is the most effective strategy to contain the pandemic.

Researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.

Oral vaccines are less immunogenic when administered in low-income countries compared to high-income countries. Several factors can contribute to this reduced efficacy, including enteric dysfunction. Technology Networks spoke with Dr. Timothy Hand, to learn about his research in this area.

This article explores how immunopeptidomics can be used to accurately determine HLA-II peptide-binding motifs and its recent utilization in exploring peptide presentation in response to SARS-CoV-2, demonstrating the capability of this technique to reveal additional insights to support therapeutic development.

A shift toward automation is a vital step forward to making breakthrough therapies more scalable and viable to help save patients’ lives. While the hurdles must be carefully considered, it is now time to accelerate digital transformation to enable the application of smart technologies, and specifically, to advance the cell and gene therapy industry.

Technology Networks is committed to keeping you updated with the latest research in this space. Here, you'll find a curation of our latest COVID-19 vaccine-related content.

This article will discuss how synthetic biology principles can be applied at various stages of therapeutic development – from elucidating disease mechanisms and identifying drug targets to producing therapeutics at scale.